These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7978784)

  • 1. The family of matrix metalloproteinases.
    Woessner JF
    Ann N Y Acad Sci; 1994 Sep; 732():11-21. PubMed ID: 7978784
    [No Abstract]   [Full Text] [Related]  

  • 2. Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix.
    Rice A; Banda MJ
    Biochemistry; 1995 Jul; 34(28):9249-56. PubMed ID: 7619826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstructed 19 kDa catalytic domain of gelatinase A is an active proteinase.
    Ye QZ; Johnson LL; Yu AE; Hupe D
    Biochemistry; 1995 Apr; 34(14):4702-8. PubMed ID: 7718575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural biochemistry and activation of matrix metalloproteases.
    Kleiner DE; Stetler-Stevenson WG
    Curr Opin Cell Biol; 1993 Oct; 5(5):891-7. PubMed ID: 8240832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of alpha 2-macroglobulin with matrix metalloproteinases and its use for identification of their active forms.
    Nagase H; Itoh Y; Binner S
    Ann N Y Acad Sci; 1994 Sep; 732():294-302. PubMed ID: 7526760
    [No Abstract]   [Full Text] [Related]  

  • 6. The origin of matrix metalloproteinases and their familial relationships.
    Murphy GJ; Murphy G; Reynolds JJ
    FEBS Lett; 1991 Sep; 289(1):4-7. PubMed ID: 1894005
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of extracellular matrix remodeling genes in a murine model of bleomycin-induced pulmonary fibrosis.
    Swiderski RE; Dencoff JE; Floerchinger CS; Shapiro SD; Hunninghake GW
    Am J Pathol; 1998 Mar; 152(3):821-8. PubMed ID: 9502424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different domain interactions are involved in the binding of tissue inhibitors of metalloproteinases to stromelysin-1 and gelatinase A.
    Nguyen Q; Willenbrock F; Cockett MI; O'Shea M; Docherty AJ; Murphy G
    Biochemistry; 1994 Mar; 33(8):2089-95. PubMed ID: 8117665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metalloproteinases and their inhibitors in matrix remodeling.
    Matrisian LM
    Trends Genet; 1990 Apr; 6(4):121-5. PubMed ID: 2132731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of the active site glutamic acid of human gelatinase A: effects on latency, catalysis, and the binding of tissue inhibitor of metalloproteinases-1.
    Crabbe T; Zucker S; Cockett MI; Willenbrock F; Tickle S; O'Connell JP; Scothern JM; Murphy G; Docherty AJ
    Biochemistry; 1994 May; 33(21):6684-90. PubMed ID: 7911325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The gelatin-binding site of human 72 kDa type IV collagenase (gelatinase A).
    Bányai L; Tordai H; Patthy L
    Biochem J; 1994 Mar; 298 ( Pt 2)(Pt 2):403-7. PubMed ID: 8135748
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A matrix metalloproteinase expressed on the surface of invasive tumour cells.
    Sato H; Takino T; Okada Y; Cao J; Shinagawa A; Yamamoto E; Seiki M
    Nature; 1994 Jul; 370(6484):61-5. PubMed ID: 8015608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinases and their inhibitors in connective tissue remodeling.
    Woessner JF
    FASEB J; 1991 May; 5(8):2145-54. PubMed ID: 1850705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Binding of gelatinases A and B to type-I collagen and other matrix components.
    Allan JA; Docherty AJ; Barker PJ; Huskisson NS; Reynolds JJ; Murphy G
    Biochem J; 1995 Jul; 309 ( Pt 1)(Pt 1):299-306. PubMed ID: 7619071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for the importance of weakly bound water for matrix metalloproteinase activity.
    Willenbrock F; Knight CG; Murphy G; Phillips IR; Brocklehurst K
    Biochemistry; 1995 Sep; 34(37):12012-8. PubMed ID: 7547939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases: a review.
    Birkedal-Hansen H; Moore WG; Bodden MK; Windsor LJ; Birkedal-Hansen B; DeCarlo A; Engler JA
    Crit Rev Oral Biol Med; 1993; 4(2):197-250. PubMed ID: 8435466
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development.
    Witty JP; Wright JH; Matrisian LM
    Mol Biol Cell; 1995 Oct; 6(10):1287-303. PubMed ID: 8573787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The 9-kDa N-terminal propeptide domain of MT1-MMP is required for the activation of progelatinase A.
    Cao J; Drews M; Lee HM; Conner C; Bahou WF; Zucker S
    Ann N Y Acad Sci; 1999 Jun; 878():710-2. PubMed ID: 10415815
    [No Abstract]   [Full Text] [Related]  

  • 19. Interactions of gelatinases with soluble and immobilized fetuin and asialofetuin.
    Ochieng J; Warfield P; Green B
    Arch Biochem Biophys; 1995 Sep; 322(1):250-5. PubMed ID: 7574683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical importance of metalloproteinases and their inhibitors.
    Krane SM
    Ann N Y Acad Sci; 1994 Sep; 732():1-10. PubMed ID: 7978783
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.